Close Menu

NEW YORK – Qiagen said on Wednesday that it has shipped its newly developed QiaStat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 as well as 21 other targets for infectious agents causing respiratory disease. It runs on the company’s automated QiaStat-Dx system, which was CE marked in 2018 and cleared by the US Food and Drug Administration in mid-2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.